Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vaxcyte, Inc. | Director | Common Stock | 7.18K | $524K | $73.00 | Jun 6, 2024 | Direct |
Vaxcyte, Inc. | Director | Common Stock | 7.11K | $519K | $73.00 | Jun 6, 2024 | By Hirth Enterprises LLC |
Aligos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 60K | Jun 27, 2024 | Direct | ||
IO Biotech, Inc. | Director | Stock Option (Right to Buy) | 45.6K | Jun 6, 2024 | Direct | ||
Vaxcyte, Inc. | Director | Stock Option (right to buy) | 7.25K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALGS | Aligos Therapeutics, Inc. | Jun 27, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Director |
PCVX | Vaxcyte, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
IOBT | IO Biotech, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
ALGS | Aligos Therapeutics, Inc. | Feb 27, 2024 | 2 | $0 | 4 | Feb 28, 2024 | Director |
ALGS | Aligos Therapeutics, Inc. | Jul 20, 2023 | 1 | $0 | 4 | Jul 21, 2023 | Director |
PCVX | Vaxcyte, Inc. | Jun 13, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
IOBT | IO Biotech, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
ALGS | Aligos Therapeutics, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
PCVX | Vaxcyte, Inc. | Jun 1, 2022 | 2 | $0 | 4 | Jun 3, 2022 | Director |
IOBT | IO Biotech, Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
IOBT | IO Biotech, Inc. | Nov 4, 2021 | 1 | $0 | 4 | Nov 8, 2021 | Director |
IOBT | IO Biotech, Inc. | Nov 4, 2021 | 0 | $0 | 3 | Nov 4, 2021 | Director |
ALGS | Aligos Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
PCVX | Vaxcyte, Inc. | Jun 2, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |